Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma
cyclophosphamide - Generic mfg.
mycophenolate mofetil - Generic mfg.
Navigating Lupus Nephritis: A Comprehensive Review of the Current Treatment Trends. (PubMed, Cureus) - Nov 29, 2024 - "Key themes include the intricate pathogenesis involving immune complex deposition and the advancing treatment landscape, which encompasses both traditional immunosuppressants such as mycophenolate mofetil (MMF) and cyclophosphamide and newer biologics like belimumab and voclosporin. The evaluation of bias risk was performed according to established protocols. This systematic approach provided a comprehensive analysis of recent developments in lupus nephritis therapy." 
Journal • Review • Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
http://www.ncbi.nlm.nih.gov/pubmed/39610592
 
Binny Bharakhada; Daksh Hardaswani; Faizanali Saiyed; Jay P Patel; Rushita J Goswami; Shrut R Chaniyara; Twisha D Mehta
 
Nov 29, 2024
 
Prev Next